Point72 Asset Management
CAMP icon

Point72 Asset Management’s CAMP4 Therapeutics CAMP Stock Holding History

Point72 Asset Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.4K Buy
+17,326
New +$82.2K ﹤0.01% 3639

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management's CAMP Position: Q1 2026 in Review

Point72 Asset Management opened a new position in CAMP4 Therapeutics (CAMP) in Q1 2026: 17,326 shares worth $76.4K. The stake represents ﹤0.01% of the portfolio and ranks #3639 among its holdings.

46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Point72 Asset Management held 17,326 shares of CAMP4 Therapeutics worth $76.4K as of Q1 2026.
  • CAMP4 Therapeutics was a new Point72 Asset Management position in Q1 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3639 holding.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.